← FDA Drug Approvals (Drugs@FDA)

AMPICILLIN AND SULBACTAM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HQ SPECLT PHARMA · Approved 2005-11-25

Drug application

FDA Application #

ANDA065188

Application type

Abbreviated New Drug Application (Generic)

Brand name

AMPICILLIN AND SULBACTAM

Generic name

AMPICILLIN AND SULBACTAM

Active ingredients

AMPICILLIN SODIUM; SULBACTAM SODIUM

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

HQ SPECLT PHARMA

Manufacturer

WG Critical Care, LLC

First approval

2005-11-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown